Pau Gorostiza, principal investigator at IBEC and ICREA profesor, appears in the media for his study co-led with Tobias Moser, director of the Institute for Auditory Neuroscience. The study presents the first light-controlled drug that produces auditory stimulation in vivo without the need of genetic manipulation.